SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
Accounting Policies [Abstract] |
|
SCHEDULE OF RECLASSIFIED PRIOR YEAR EXPENSES MEASUREMENTS |
SCHEDULE OF RECLASSIFIED PRIOR YEAR EXPENSES MEASUREMENTS
Account |
|
Previously
Recorded
Balance |
|
|
Corrected
Balance |
|
|
Reclassification
Made |
|
|
Previously
Recorded
Balance |
|
|
Corrected
Balance |
|
|
Reclassification
Made |
|
|
|
Three Months Ended June 30, 2024 |
|
|
Six Months Ended June 30, 2024 |
|
Account |
|
Previously
Recorded
Balance |
|
|
Corrected
Balance |
|
|
Reclassification
Made |
|
|
Previously
Recorded
Balance |
|
|
Corrected
Balance |
|
|
Reclassification
Made |
|
Statement of Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
15,570,741 |
|
|
|
14,950,934 |
|
|
|
(619,807 |
) |
|
|
31,061,422 |
|
|
|
30,190,321 |
|
|
|
(871,101 |
) |
Cost of goods sold |
|
|
9,866,756 |
|
|
|
9,246,949 |
|
|
|
(619,807 |
) |
|
|
18,343,293 |
|
|
|
17,472,192 |
|
|
|
(871,101 |
) |
Gross profit |
|
|
5,703,985 |
|
|
|
5,703,985 |
|
|
|
- |
|
|
|
12,718,129 |
|
|
|
12,718,129 |
|
|
|
- |
|
|
SCHEDULE OF FAIR VALUE MEASUREMENTS |
The
following table summarizes the financial instruments of the Company at fair value based on the valuation approach applied to each class
of security as of June 30, 2024:
SCHEDULE OF FAIR VALUE MEASUREMENTS
|
|
Carrying Value at June
30, 2025
|
|
|
Quoted Prices in Active Markets for Identical Assets (Level 1)
|
|
|
Significant Other Observable Inputs (Level 2)
|
|
|
Significant Unobservable Inputs (Level 3)
|
|
|
|
|
|
|
Fair Value Measurement at Reporting Date Using |
|
|
|
Carrying Value at June
30, 2024
|
|
|
Quoted Prices in Active Markets for Identical Assets (Level 1)
|
|
|
Significant Other Observable Inputs (Level 2)
|
|
|
Significant Unobservable Inputs (Level 3)
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value of potential Share Adjustment |
|
$ |
30,441,480 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
30,441,480 |
|
Total Liabilities |
|
$ |
30,441,480 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
30,441,480 |
|
|
SCHEDULE OF FAIR VALUE OF SHARE ADJUSTMENT |
The
following table presents a reconciliation of the opening and closing balances of the Fair Value of Share Adjustment for the six months
ended June 30, 2025:
SCHEDULE OF FAIR VALUE OF SHARE ADJUSTMENT
|
|
Fair Value of
Share Adjustment |
|
|
|
|
|
Balance at December 31, 2024 |
|
$ |
9,299,703 |
|
Fair Value of Shares Issued |
|
|
(5,607,174 |
) |
Gain on Fair Value of Share Adjustment |
|
|
(3,692,529 |
) |
Balance at June 30, 2025 |
|
$ |
- |
|
|
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF NET LOSS PER SHARE |
The
following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these
potential shares was antidilutive due to the Company’s net income (loss) position even though the exercise price could be less
than the average market price of the Class A common stock:
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF NET LOSS PER SHARE
|
|
2025 |
|
|
2024 |
|
|
|
Six Months Ended June 30, |
|
|
|
2025 |
|
|
2024 |
|
Warrants |
|
|
38,825,000 |
|
|
|
39,350,000 |
|
Stock options |
|
|
3,602,500 |
|
|
|
4,760,000 |
|
Stock options [Member] |
|
|
3,602,500 |
|
|
|
4,760,000 |
|
Acquisition Stock Consideration Payable |
|
|
- |
|
|
|
264,708,523 |
|
Total |
|
|
42,427,500 |
|
|
|
308,818,523 |
|
Antidilutive securities |
|
|
42,427,500 |
|
|
|
308,818,523 |
|
|